Lupin arm gets tentative FDA nod for anti-bacterial drug Industry-The Economic Times — September 1, 2016 comments off Gavis has received tentative approval for its Azithromycin for oral suspension USP from the USFDA, Lupin said in a BSE filing.
Gavis has received tentative approval for its Azithromycin for oral suspension USP from the USFDA, Lupin said in a BSE filing.